Showing results (31-40 of 158) with videos related to
Sort By:
Pageof 16
European Journal of Immunology|May 15, 2013
Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouseEva M Sturm, Kimberly D Dyer, Caroline M Percopo, et al.Biochimica Et Biophysica Acta|December 3, 2014
Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDLSanja Curcic, Michael Holzer, Robert Frei, et al.The Journal of Biological Chemistry|November 20, 2012
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55Julia Kargl, Nariman Balenga, Gerald P Parzmair, et al.Molecular Pharmacology|May 5, 2005
Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2Jesper Mosolff Mathiesen, Trond Ulven, Lene Martini, et al.Journal of Molecular Medicine (Berlin, Germany)|September 12, 2012
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanismsJulia Kargl, Johannes Haybaeck, Angela Stančić, et al.Atherosclerosis|December 7, 2010
Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cellsMonika Riederer, Margarete Lechleitner, Andelko Hrzenjak, et al.Cytometry. Part B, Clinical Cytometry|June 10, 2010
CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulationEva M Sturm, Bettina Kranzelbinder, Akos Heinemann, et al.Antioxidants & Redox Signaling|May 17, 2017
Increased Expression of p22phox Mediates Airway Hyperresponsiveness in an Experimental Model of AsthmaChandran Nagaraj, Hans Michael Haitchi, Akos Heinemann, et al.The Journal of Pharmacology and Experimental Therapeutics|May 4, 2013
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell functionJulia Kargl, Andrew J Brown, Liisa Andersen, et al.Biochemical Pharmacology|July 18, 2021
The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophiliaPetra Luschnig, Melanie Kienzl, David Roula, et al.Pageof 16